Patents by Inventor Bryan Edward Jones

Bryan Edward Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-Coronavirus Antibodies and Methods of Use
    Publication number: 20220356229
    Abstract: Antibodies that bind SARS-CoV Spike protein, SARS-CoV-2 Spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2.
    Type: Application
    Filed: March 4, 2021
    Publication date: November 10, 2022
    Applicants: AbCellera Biologics Inc., The United States of America, as represented by the Secretary, Department of Health and Human Svcs.
    Inventors: Kathryn WESTENDORF, Stefanie ZENTELIS, Krithika MUTHURAMAN, Kevin JEPSON, Ester FALCONER, John MASCOLA, Barney GRAHAM, Kizzmekia CORBETT, Julie LEDGERWOOD, Lingshu WANG, Olubukola ABIONA, Wei SHI, Wing-pui KONG, Yi ZHANG, Bryan Edward JONES, Denisa FOSTER, Julian DAVIES, Qing CHAI, Christopher Carl FRYE, Ganapathy GOPALRATHNAM, Jörg HENDLE, John Michael SAUDER, Jeffrey Streetman BOYLES, Anna PUSTILNIK
  • Anti-coronavirus antibodies and methods of use
    Patent number: 11447541
    Abstract: Antibodies that bind SARS-CoV Spike protein, SARS-CoV-2 Spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: September 20, 2022
    Assignees: AbCellera Biologies Inc., The United States of America, as represented by the Secretary, Department of Health and Human Svcs.
    Inventors: Kathryn Westendorf, Stefanie Zentelis, Krithika Muthuraman, Kevin Jepson, Ester Falconer, John Mascola, Barney Graham, Kizzmekia Corbett, Julie Ledgerwood, Lingshu Wang, Olubukola Abiona, Wei Shi, Wing-pui Kong, Yi Zhang, Bryan Edward Jones, Denisa Foster, Julian Davies, Qing Chai, Christopher Carl Frye, Ganapathy Gopalrathnam, Jörg Hendle, John Michael Sauder, Jeffrey Streetman Boyles, Anna Pustilnik
  • Anti-coronavirus antibodies and methods of use
    Patent number: 11370828
    Abstract: Antibodies that bind SARS-CoV spike protein, SARS-CoV-2 spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: June 28, 2022
    Assignees: AbCellera Biologies Inc., The United States of America, as represented by the Secretary, Department of Health and Human Svcs.
    Inventors: Kathryn Westendorf, Stefanie Zentelis, Krithika Muthuraman, Kevin Jepson, Ester Falconer, John Mascola, Barney Graham, Kizzmekia Corbett, Julie Ledgerwood, Lingshu Wang, Olubukola Abiona, Wei Shi, Wing-pui Kong, Yi Zhang, Bryan Edward Jones, Denisa Foster, Julian Davies, Qing Chai, Christopher Carl Frye, Ganapathy Gopalrathnam, Jörg Hendle, John Michael Sauder, Jeffrey Streetman Boyles, Anna Pustilnik
  • Anti-Coronavirus Antibodies and Methods of Use
    Publication number: 20210388066
    Abstract: Antibodies that bind SARS-CoV spike protein, SARS-CoV-2 spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2.
    Type: Application
    Filed: June 22, 2021
    Publication date: December 16, 2021
    Applicants: AbCellera Biologics Inc., The United States of America, as represented by the Secretary, Department of Health and Human Svcs.
    Inventors: Kathryn WESTENDORF, Stefanie ZENTELIS, Krithika MUTHURAMAN, Kevin JEPSON, Ester FALCONER, John MASCOLA, Barney GRAHAM, Kizzmekia CORBETT, Julie LEDGERWOOD, Lingshu WANG, Olubukola ABIONA, Wei SHI, Wing-pui KONG, Yi ZHANG, Bryan Edward JONES, Denisa FOSTER, Julian DAVIES, Qing CHAI, Christopher Carl FRYE, Ganapathy GOPALRATHNAM, Jörg HENDLE, John Michael SAUDER, Jeffrey Streetman BOYLES, Anna PUSTILNIK
  • Anti-Coronavirus Antibodies and Methods of Use
    Publication number: 20210292393
    Abstract: Antibodies that bind SARS-CoV spike protein, SARS-CoV-2 spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2.
    Type: Application
    Filed: December 9, 2020
    Publication date: September 23, 2021
    Applicants: AbCellera Biologics Inc., The United States of America, as represented by the Secretary, Department of Health and Hunman Servi
    Inventors: Kathryn WESTENDORF, Stefanie ZENTELIS, Krithika MUTHURAMAN, Kevin JEPSON, Ester FALCONER, John MASCOLA, Barney GRAHAM, Kizzmekia CORBETT, Julie LEDGERWOOD, Lingshu WANG, Olubukola ABIONA, Wei SHI, Wing-pui KONG, Yi ZHANG, Bryan Edward JONES, Denisa FOSTER, Julian DAVIES, Qing CHAI, Christopher Carl FRYE, Ganapathy GOPALRATHNAM, Jörg HENDLE, John Michael SAUDER, Jeffrey Streetman BOYLES, Anna PUSTILNIK
  • METHOD FOR ADMINISTERING GLP-1 MOLECULES
    Publication number: 20150202296
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Application
    Filed: January 22, 2015
    Publication date: July 23, 2015
    Inventors: Mohammed Amin KHAN, Bryan Edward Jones, John Mcneill McGill
  • METHOD FOR ADMINISTERING GLP-1 MOLECULES
    Publication number: 20140005106
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Application
    Filed: July 16, 2013
    Publication date: January 2, 2014
    Applicant: Emisphere Technologies, Inc.
    Inventors: Mohammed Amin KHAN, Bryan Edward Jones, John Mcneill McGill
  • Formulation comprising GLP-1
    Patent number: 8492330
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Grant
    Filed: January 12, 2011
    Date of Patent: July 23, 2013
    Assignee: Emisphere Technologies, Inc.
    Inventors: Mohammed Amin Khan, Bryan Edward Jones, John McNeill McGill
  • Treating acute renal failure with soluble thrombomodulin variants
    Patent number: 8076298
    Abstract: The present invention provides a method for preventing and/or treating subjects with acute renal failure caused by a variety of conditions. The method comprises administering to the subject soluble thrombomodulin which does not activate Protein C. In conjunction with standard of care, soluble thrombomodulin that does not activate Protein C will prevent or reduce acute kidney injury and subsequent morbidity and mortality.
    Type: Grant
    Filed: December 10, 2007
    Date of Patent: December 13, 2011
    Assignees: Eli Lilly and Company, Indiana University Research and Technology Corporation
    Inventors: Brian William Grinnell, Bryan Edward Jones, Bruce A. Molitoris
  • Anti-myostatin antibodies
    Patent number: 8066995
    Abstract: Anti-myostatin antibodies are identified that are characterized as having high affinity and may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful for increasing muscle mass, increasing bond density, or for the treatment of various disorders in mammalian and avian species, X17251.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: November 29, 2011
    Assignee: Eli Lilly and Company
    Inventors: Julian Davies, Bryan Edward Jones, Andrew Ihor Korytko, Pamela Jean Mitchell, Rosamund Carol Smith, Linda O'Bryan (Nee Tobias), Rong Wang
  • METHOD FOR ADMINISTERING GLP-1 MOLECULES
    Publication number: 20110178006
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Application
    Filed: January 12, 2011
    Publication date: July 21, 2011
    Applicant: Emisphere Technologies, Inc.
    Inventors: Mohommed Amin KHAN, Bryan Edward Jones, John McNeil McGill
  • Method for administering GLP-1 molecules
    Patent number: 7939494
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: May 10, 2011
    Assignee: Emisphere Technologies, Inc.
    Inventors: Mohammed Amin Khan, Bryan Edward Jones, John McNeill McGill
  • TGF-beta binding antibodies
    Patent number: 7927593
    Abstract: The present invention provides very high affinity antibodies, or antigen-binding fragments thereof, that neutralize mature human TGF-?1, TGF-?2, and TGF-?3. The antibodies of the invention are useful for treating cell proliferative disorders in a mammal.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: April 19, 2011
    Assignee: Eli Lilly and Company
    Inventors: Bryan Edward Jones, James David Pancook, Scott William Rowlinson
  • TGF-BETA BINDING ANTIBODIES
    Publication number: 20100136021
    Abstract: The present invention provides very high affinity antibodies, or antigen-binding fragments thereof, that neutralize mature human TGF-?1, TGF-?2, and TGF-?3. The antibodies of the invention are useful for mating cell proliferative disorders in a mammal.
    Type: Application
    Filed: January 26, 2010
    Publication date: June 3, 2010
    Applicant: ELI LILLY AND COMPANY
    Inventors: Bryan Edward Jones, James D. Pancook, Scott William Rowlinson
  • TREATING ACUTE RENAL FAILURE WITH SOLUBLE THROMBOMODULIN VARIANTS
    Publication number: 20100087368
    Abstract: The present invention provides a method for preventing and/or treating subjects with acute renal failure caused by a variety of conditions. The method comprises administering to the subject soluble thrombomodulin which does not activate Protein C. In conjunction with standard of care, soluble thrombomodulin that does not activate Protein C will prevent or reduce acute kidney injury and subsequent morbidity and mortality.
    Type: Application
    Filed: December 10, 2007
    Publication date: April 8, 2010
    Applicant: ELI LILLY AND COMPANY
    Inventors: Brian William Grinnell, Bryan Edward Jones, Bruce A. Molitoris
  • ANTI-MYOSTATIN ANTIBODIES
    Publication number: 20100080811
    Abstract: Anti-myostatin antibodies are identified that are characterized as having high affinity and may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful for increasing muscle mass, increasing bone density, or for the treatment of various disorders in mammalian and avian species.
    Type: Application
    Filed: November 3, 2009
    Publication date: April 1, 2010
    Inventors: JULIAN DAVIES, BRYAN EDWARD JONES, ANDREW IHOR KORYTKO, PAMELA JEAN MITCHELL, ROSAMUND CAROL SMITH, LINDA MAUREEN O'BRYAN (NEE TOBIAS), RONG WANG
  • Methods of treating diseases with activated protein C
    Patent number: 7638123
    Abstract: Method of treating a disease or pathological condition with activated protein C or a compound having activated protein C activity by direct regulation of the expression of specific genes associated with the disease or pathological condition.
    Type: Grant
    Filed: February 26, 2007
    Date of Patent: December 29, 2009
    Assignee: Eli Lilly and Company
    Inventors: Angelina Vucic Ciaccia, Lawrence Mark Gelbert, Brian William Grinnell, Bryan Edward Jones, David Eugene Joyce
  • Anti-myostatin antibodies
    Patent number: 7632499
    Abstract: Anti-myostatin antibodies are identified that are characterized as having high affinity and may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful for increasing muscle mass, increasing bone density, or for the treatment of various disorders in mammalian and avian species.
    Type: Grant
    Filed: October 5, 2006
    Date of Patent: December 15, 2009
    Assignee: Eli Lilly and Company
    Inventors: Julian Davies, Bryan Edward Jones, Andrew Ihor Korytko, Pamela Jean Mitchell, Rosamund Carol Smith, Linda Maureen O'Bryan, Rong Wang
  • METHOD FOR ADMINISTERING GLP-1 MOLECULES
    Publication number: 20090286735
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Application
    Filed: April 9, 2009
    Publication date: November 19, 2009
    Inventors: Mohammed Amin Khan, Bryan Edward Jones, John McNeill McGill
  • Passenger safety restraint, seat height adjustment assembly and method of restraining a passenger
    Publication number: 20090212549
    Abstract: A restraining kit for restraining a person in a vehicle, includes a wearable harness which is wearable by a person and securing means for securing the wearable harness to a body of the vehicle when it is being worn by the person. The wearable harness includes shoulder straps, a waist strap and a crotch strap and the securing means is a second harness which is secured or securable to a seat of the vehicle. The restraining kit includes a buckle clip mechanism by which the wearable harness is securable to the second harness.
    Type: Application
    Filed: May 8, 2006
    Publication date: August 27, 2009
    Inventor: Bryan Edward Jones